BMHS Stock Growth in the Middle of 2022
Investors who invest in the capital market, especially the stock market, must monitor stock movements regularly. Knowing the ups and downs of stock prices allows you to decide when it's time to buy or sell the asset.
One of the shares traded on the stock exchange is PT Bundamedik Tbk or BMHS (Bundamedik Healthcare System). The shares of PT Bundamedik Tbk have been officially listed on the Indonesian stock market since July 6, 2021, with the stock code BMHS.
Towards the middle of 2022, the performance of BMHS shares showed a positive trend. This is an exciting opportunity for investors, especially for those of you who are interested in the healthcare sector.
Learning BMHS Stock Movements
Entering the second quarter of 2022, the pandemic's situation is gradually improving. Community activities are also getting better and more regular. However, the government continues to encourage the public to continue to implement the health protocols.
The health industry is still an exciting sector to pay attention to, especially during the pandemic. Ahead of the stock exchange trading holiday related to the 2022 Eid al-Fitr joint leave, there were several exciting stock price movements in the stock market.
The movement of BMHS shares before the stock market's closing ahead of the Idul Fitri holiday still showed a correction since the beginning of the year. The following is some information related to BMHS's stock performance profile and prospects:
As of April 14, 2022, BMHS shares are still corrected 7% since the beginning of the year for Rp 765 per share.
The average trading volume in the March 2022 period reached Rp 12 billion per day, including liquid stocks.
The average trading volume for the March 2022 period is 3,966,327 lots
There was an increase in the number of trading volumes on an MoM basis by 47% compared to the February period
BMHS stock movements throughout 2021 recorded business performance with net profit growth reaching Rp 219.29 billion or 142% year on year (YoY)
This is in line with the achievement of operating income growth of Rp. 1.71 trillion, or equivalent to 49% YoY
BMHS Stock Technical Analysis
To develop your investment or trading strategy, perform fundamental and technical analyses. Technical analysis is an analytical technique that observes the movement of stock prices on the stock exchange based on specific chart patterns.
Regarding BMHS shares, there is a potential for a bullish reversal in the short term. This means that there is an opportunity for a stock movement to reverse direction from a downtrend to an uptrend.
BMHS shares have the potential to test the nearest resistance at the price level of Rp. 820. The test of resistance considers the closest support at the price level of Rp. 740. This analysis is certainly important to support your trading or investment plans.
BMHS Business Plan 2022
As a company engaged in the health sector, Bundamedik Healthcare System has prepared a business plan for 2022.
1. Gradual Business Development
BMHS has pocketed Rp 1 trillion in funds for business development purposes. The funds from the BCA Bank loan will later be used to develop health services related to hospitals.
Apart from the stock movement still correcting, BMHS is committed to continuing to develop the hospital ecosystem, such as IVF clinics, laboratories, and others, so that the public can access integrated health services.
2. Hospital Acquisition
Nurhadi Yudiyanto, as Managing Director of Bundamedik, revealed that BMHS is also exploring two hospitals to be acquired. Still located in Greater Jakarta, the acquisition process is expected to be completed in the first quarter of 2022.
3. Business Expansion
Bundamedik also continues developing clinics and labs and adding branches to the pharmacy distribution unit. In 2022, BMHS plans to expand to other parts of Indonesia, such as North Sumatra, Surabaya, and Bali, to Sulawesi, especially Makassar.
The public can be involved and contribute to the provision of health care facilities through BMHS stock transactions on the stock exchange. If you are interested in investing in the health sector, observing the movement of BMHS shares first is better.
4. Highest Non-Covid Income Over the Last 2 Years
In the first quarter of 2022, PT Bundamedik Tbk managed to record Non-Covid revenue of Rp. 375 billion, which is the highest figure for the last 2 years. This is mainly supported by the strong business fundamentals of BMHS for Non-Covid health services and will continue to grow along with the easing of the pandemic in Indonesia.
Also Read: BMHS Investment in Bandung Heart Hospital